Cargando…

Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients

Bone and joint infection (BJI) epidemiology and outcomes in solid organ transplant recipients (SOTr) remain largely unknown. We aim to describe BJI in a multi‐center cohort of SOTr (Swiss Transplant Cohort Study). All consecutive SOTr with BJI (01.05.2008–31.12.2019) were included. A nested case–con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pham, Truong‐Thanh, Andrey, Diego O., Stampf, Susanne, Burkhard, Sara H., Hirzel, Cédric, Tschopp, Johnathan, Ullrich, Kathrin, Strahm, Carol, Schreiber, Peter W., Boillat‐Blanco, Noémie, Garzoni, Christian, Khanna, Nina, Manuel, Oriol, Mueller, Nicolas J., Suva, Domizio, van Delden, Christian, Uçkay, Ilker, Neofytos, Dionysios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087422/ https://www.ncbi.nlm.nih.gov/pubmed/36031963 http://dx.doi.org/10.1111/ajt.17184

Ejemplares similares

Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland
por: Walti, Laura N., et al.
Publicado: (2023)

Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update
por: Neofytos, Dionysios, et al.
Publicado: (2023)

In vivo interactions of continuous flucloxacillin infusion and high-dose oral rifampicin in the serum of 15 patients with bone and soft tissue infections due to Staphylococcus aureus - a methodological and pilot study
por: Garzoni, Christian, et al.
Publicado: (2014)

Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018
por: Kohler, Philipp, et al.
Publicado: (2021)

Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study
por: Walti, Laura N., et al.
Publicado: (2020)

Antibiotic Prophylaxis During Dental Procedures in Patients with Prosthetic Joints
por: Sendi, Parham, et al.
Publicado: (2016)

Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study
por: van Delden, Christian, et al.
Publicado: (2020)

Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates
por: Sava, Mihaela, et al.
Publicado: (2022)

Epidemiology and outcomes of medically attended and microbiologically confirmed bacterial foodborne infections in solid organ transplant recipients
por: van den Bogaart, Lorena, et al.
Publicado: (2021)

Bone metabolism dynamics in the early post-transplant period following kidney and liver transplantation
por: Schreiber, Peter W., et al.
Publicado: (2018)

Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients
por: Royston, Léna, et al.
Publicado: (2021)

A systematic review of phage therapy applied to bone and joint infections: an analysis of success rates, treatment modalities and safety
por: Genevière, Joseph, et al.
Publicado: (2021)

Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study
por: Royston, Léna, et al.
Publicado: (2021)

Streptococcus sinensis Endocarditis outside Hong Kong
por: Uçkay, Ilker, et al.
Publicado: (2007)

Low incidence of severe respiratory syncytial virus infections in lung transplant recipients despite the absence of specific therapy
por: Uçkay, Ilker, et al.
Publicado: (2010)

Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients
por: Olearo, Flaminia, et al.
Publicado: (2020)

Second Periprosthetic Joint Infection Caused by Streptococcus dysgalactiae: How Genomic Sequencing Can Help Defining the Best Therapeutic Strategy
por: Pham, Truong-Thanh, et al.
Publicado: (2020)

When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?
por: Roth, Romain Samuel, et al.
Publicado: (2022)

CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients
por: Chavaz, Lara, et al.
Publicado: (2023)

Clinical Considerations of Isavuconazole Administration in High-Risk Hematological Patients: A Single-Center 5-Year Experience
por: Kronig, Ilona, et al.
Publicado: (2021)

Daily use of public transportation and incidence of symptomatic COVID-19 among healthcare workers during the peak of a pandemic wave in Zurich, Switzerland
por: Steinwender, Ludwig, et al.
Publicado: (2022)

Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment
por: Petek, Daniel, et al.
Publicado: (2019)

Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation
por: Glampedakis, Emmanouil, et al.
Publicado: (2021)

Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?
por: Roth, Romain Samuel, et al.
Publicado: (2021)

Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 days
por: Truong-Thanh,, et al.
Publicado: (2022)

Clinical relevance of occult infections in spinal pseudarthrosis revision()
por: Burkhard, Marco D., et al.
Publicado: (2022)

Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections
por: Roth, Romain Samuel, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Royston, Léna, et al.
Publicado: (2022)

Changing perioperative prophylaxis during antibiotic therapy and iterative debridement for orthopedic infections?
por: Wuarin, Lydia, et al.
Publicado: (2019)

Treating Diabetic Foot Osteomyelitis: A Practical State-of-the-Art Update
por: Lipsky, Benjamin A., et al.
Publicado: (2021)

Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients
por: Atamna, Alaa, et al.
Publicado: (2023)

IGF1 Is a Common Target Gene of Ewing's Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells
por: Cironi, Luisa, et al.
Publicado: (2008)

Epigenetic Features of Human Mesenchymal Stem Cells Determine Their Permissiveness for Induction of Relevant Transcriptional Changes by SYT-SSX1
por: Cironi, Luisa, et al.
Publicado: (2009)

Cohort profile: The Swiss Transplant Cohort Study (STCS): A nationwide longitudinal cohort study of all solid organ recipients in Switzerland
por: Stampf, Susanne, et al.
Publicado: (2021)

Perioperative Urinary Catheter Use and Association to (Gram-Negative) Surgical Site Infection after Spine Surgery
por: Ansorge, Alexandre, et al.
Publicado: (2023)

Redefining Foot Symptoms in a Kidney-Pancreas-Transplanted Type 1 Diabetic Patient: Challenging the Conventional Charcot Foot Diagnosis
por: Memaj, Plator, et al.
Publicado: (2023)

Staffing level: a determinant of late-onset ventilator-associated pneumonia
por: Hugonnet, Stéphane, et al.
Publicado: (2007)

Free versus Pedicled Flaps for Lower Limb Reconstruction: A Meta-Analysis of Comparative Studies
por: Scampa, Matteo, et al.
Publicado: (2022)

Free versus Pedicled Flaps for Lower Limb Reconstruction: A Meta-Analysis of Comparative Studies
por: Scampa, Matteo, et al.
Publicado: (2023)

Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma
por: Zanella, Marie-Céline, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bimuaikv5u75najrtdthft41ui